BACKGROUND: WHO recommends initiating combination antiretroviral treatment at the minimal CD4 cell threshold of 350 cells/μl. In sub-Saharan Africa, the time for a recently infected patient to reach this threshold is unclear. METHOD: We estimated the probability of reaching different CD4 cell thresholds over time in the ANRS 1220 cohort of HIV-1 seroconverters in Côte d'Ivoire. CD4 cell slopes were estimated using a mixed linear model. Probabilities of crossing the 350 and 500 cells/μl CD4 cell thresholds were estimated by the Kaplan-Meier method. RESULTS: Between 1997 and 2009, 304 recent seroconverters have been enrolled in the Primo-CI cohort (62% men, median baseline age 29 years and median time since the estimated date of seroconversion 9 months). The probability of having a first CD4 cell count below 500 cells/μl was 0.57, 0.72, 0.79 and 0.84 at study entry, 2, 4 and 6 years, respectively. For a first CD4 cell count below 350 cells/μl, these figures were 0.29, 0.40, 0.55 and 0.67. The time for 75% of patients to reach the threshold was 3.0 years for 500 cells/μl and 7.0 years for 350 cells/μl.
BACKGROUND: WHO recommends initiating combination antiretroviral treatment at the minimal CD4 cell threshold of 350 cells/μl. In sub-Saharan Africa, the time for a recently infected patient to reach this threshold is unclear. METHOD: We estimated the probability of reaching different CD4 cell thresholds over time in the ANRS 1220 cohort of HIV-1 seroconverters in Côte d'Ivoire. CD4 cell slopes were estimated using a mixed linear model. Probabilities of crossing the 350 and 500 cells/μl CD4 cell thresholds were estimated by the Kaplan-Meier method. RESULTS: Between 1997 and 2009, 304 recent seroconverters have been enrolled in the Primo-CI cohort (62% men, median baseline age 29 years and median time since the estimated date of seroconversion 9 months). The probability of having a first CD4 cell count below 500 cells/μl was 0.57, 0.72, 0.79 and 0.84 at study entry, 2, 4 and 6 years, respectively. For a first CD4 cell count below 350 cells/μl, these figures were 0.29, 0.40, 0.55 and 0.67. The time for 75% of patients to reach the threshold was 3.0 years for 500 cells/μl and 7.0 years for 350 cells/μl.
Authors: C Costello; K E Nelson; V Suriyanon; S Sennun; S Tovanabutra; C M Heilig; S Shiboski; D J Jamieson; V Robison; K Rungruenthanakit; A Duerr Journal: Int J Epidemiol Date: 2005-02-28 Impact factor: 7.196
Authors: Albert Minga; Christine Danel; Yao Abo; Lambert Dohoun; Dominique Bonard; Ali Coulibaly; Julien Duvignac; François Dabis; Roger Salamon; Xavier Anglaret Journal: Bull World Health Organ Date: 2007-02 Impact factor: 9.408
Authors: Roberto Muga; Inmaculada Ferreros; Klaus Langohr; Patricia García de Olalla; Jorge Del Romero; Manuel Quintana; Ignacio Alastrue; Josefina Belda; Jordi Tor; Santiago Pérez-Hoyos; Julia Del Amo Journal: AIDS Date: 2007-11-30 Impact factor: 4.177
Authors: Olivia Keiser; Kathryn Anastos; Mauro Schechter; Eric Balestre; Landon Myer; Andrew Boulle; David Bangsberg; Hapsatou Touré; Paula Braitstein; Eduardo Sprinz; Denis Nash; Mina Hosseinipour; François Dabis; Margaret May; Martin W G Brinkhof; Matthias Egger Journal: Trop Med Int Health Date: 2008-03-27 Impact factor: 2.622
Authors: Simon Wandel; Matthias Egger; Ram Rangsin; Kenrad E Nelson; Caroline Costello; Charlotte Lewden; Tom Lutalo; Anthony Ndyanabo; Jim Todd; Lieve Van der Paal; Albert Minga; Marcel Zwahlen Journal: Sex Transm Infect Date: 2008-08 Impact factor: 3.519
Authors: Jacques D A Ndawinz; Xavier Anglaret; Eric Delaporte; Sinata Koulla-Shiro; Delphine Gabillard; Albert Minga; Dominique Costagliola; Virginie Supervie Journal: Bull World Health Organ Date: 2015-06-01 Impact factor: 9.408
Authors: Federica Giardina; Ethan O Romero-Severson; Maria Axelsson; Veronica Svedhem; Thomas Leitner; Tom Britton; Jan Albert Journal: Int J Epidemiol Date: 2019-12-01 Impact factor: 7.196